Concepedia

Author

Ole B. Suhr

Umeå UniversityORCID

Also Known As

Bjorn Pilebro, Intissar Anan, K.B. Suhr, O B Suhr, O SUHR, O Suhr, O. B. SUHR, O. B. Suhr, O. B. Suhr, K. Lang, L. Wikstrom, I, O. SUHR

306

Publications

18K

Citations

64

H-Index

121

Concepts

All Affiliations

Umeå UniversityKumamoto UniversityUppsala UniversityInsermKarolinska University Hospital
OB

About

Ole B. Suhr is an author at Umeå University specializing in medicine, neuropathology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

28

56

4K

2

Health Sciences

2

2

124

3

Business

1

1

19

4

Engineering

1

1

18

5

Language Studies

1

1

34

Ole B. Suhr

×

162

Publications

15.7K

Citations

58

H-Index

YearCitations

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan,

New England Journal of Medicine

2018

2.8K

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

Teresa Coelho, David Adams, Ana Silva,

New England Journal of Medicine

2013

947

Tafamidis for transthyretin familial amyloid polyneuropathy

Teresa Coelho, Luı́s F. Maia, Ana Silva,

Neurology

2012

774

Repurposing Diflunisal for Familial Amyloid Polyneuropathy

John L. Berk, Ole B. Suhr, Laura Obici,

JAMA

2013

679

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis

Gösta Holmgren, Lars Steen, Ole B. Suhr,

The Lancet

1993

580

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis

Mathew S. Maurer, Mazen Hanna, Martha Grogan,

Journal of the American College of Cardiology

2016

507

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

Scott D. Solomon, David Adams, Arnt V. Kristen,

Circulation

2019

450

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

Teresa Coelho, Luı́s F. Maia, Ana Silva,

Journal of Neurology

2013

333

Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study

Ole B. Suhr, Teresa Coelho, Juan Buades,

Orphanet Journal of Rare Diseases

2015

316

THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

Teresa Coelho, Mathew S. Maurer, Ole B. Suhr

Current Medical Research and Opinion

2012

312

Page 1